REACT: a randomized trial to assess the efficacy and safety of clazosentan for preventing clinical deterioration due to delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage

Stephan Mayer; Nicolas Bruder; Giuseppe Citero; Andreas Gruber

doi:10.3171/2024.4.JNS232191

REACT: a randomized trial to assess the efficacy and safety of clazosentan for preventing clinical deterioration due to delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage

Stephan Mayer, Nicolas Bruder, Giuseppe Citero, Andreas Gruber

Department of Neurosurgery

Research output: Contribution to journal › Article › peer-review

Original language	German (Austria)
Number of pages	12
Journal	Journal of Neurosurgery
DOIs	https://doi.org/10.3171/2024.4.JNS232191
Publication status	Published - 2024

Fields of science

302051 Neurosurgery

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.3171/2024.4.JNS232191

Cite this

@article{264d927284a6497b8f4eeb1e476566c2,

title = "REACT: a randomized trial to assess the efficacy and safety of clazosentan for preventing clinical deterioration due to delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage",

author = "Stephan Mayer and Nicolas Bruder and Giuseppe Citero and Andreas Gruber",

year = "2024",

doi = "10.3171/2024.4.JNS232191",

language = "Deutsch ({\"O}sterreich)",

journal = "Journal of Neurosurgery",

issn = "0022-3085",

}

TY - JOUR

T1 - REACT: a randomized trial to assess the efficacy and safety of clazosentan for preventing clinical deterioration due to delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage

AU - Mayer, Stephan

AU - Bruder, Nicolas

AU - Citero, Giuseppe

AU - Gruber, Andreas

PY - 2024

Y1 - 2024

U2 - 10.3171/2024.4.JNS232191

DO - 10.3171/2024.4.JNS232191

M3 - Artikel

SN - 0022-3085

JO - Journal of Neurosurgery

JF - Journal of Neurosurgery

ER -